Toronto - Delayed Quote CAD
Oncolytics Biotech Inc. (ONC.TO)
0.8100
-0.0300
(-3.57%)
At close: 3:59:30 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-26,966
-26,966
-28,448
-23,355
-22,433
Investing Cash Flow
-239
-239
20,222
-20,403
-286
Financing Cash Flow
6,636
6,636
31,994
12,205
33,015
End Cash Position
15,942
15,942
34,912
11,666
41,262
Income Tax Paid Supplemental Data
184
184
120
46
35
Capital Expenditure
-239
-239
-8
-55
-286
Issuance of Capital Stock
6,919
6,919
31,620
12,574
32,912
Repayment of Debt
-348
-348
-407
-381
-366
Free Cash Flow
-27,205
-27,205
-28,456
-23,410
-22,719
12/31/2021 - 6/1/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MDNA.TO Medicenna Therapeutics Corp.
1.0500
0.00%
TH.TO Theratechnologies Inc.
3.9100
+3.17%
BCT.TO BriaCell Therapeutics Corp.
8.45
+18.68%
APS.TO Aptose Biosciences Inc.
2.8000
-14.63%
RVX.TO Resverlogix Corp.
0.0400
+14.29%
IMVIF IMV Inc.
0.0001
0.00%
CYBN.NE Cybin Inc.
9.73
+1.88%
HBP.TO Helix BioPharma Corp.
0.7800
+1.30%
FRX.TO Fennec Pharmaceuticals Inc.
7.08
0.00%
MSB.AX Mesoblast Limited
1.7900
+5.29%